Reaktion #95802
ord-aa74e398b9904c06bc3b9140ca47a282
Reaktionsgleichung
Edukte
Reagenzien
Lösungsmittel
Reaktionsbedingungen
Aufarbeitung
- 1SonstigeThe mixture is evaporated in vacuo
- 2Temperaturheated
- 3Temperaturunder reflux for 22 hours
- 4SonstigeAfter evaporation in vacuo
- 5workup.ADDITIONthe residue is treated with water
- 6Extraktionextracted three times with 30 ml of chloroform each time
- 7WaschenThe combined chloroform phases are washed three times with 20 ml of water each time
- 8Trocknendried over magnesium sulphate
- 9Sonstigeevaporated
- 10SonstigeAfter recrystallisation from ethyl acetate/n-hexane
Vorschrift
934 mg (3 mmol) of ethyl (S)-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylate are stirred at 60° C. for 48 hours with 198 mg (3 mmol) of potassium cyanide in 30 ml of dry 2-propanol. The mixture is evaporated in vacuo. The residue is treated with 30 ml of 2-propanol and 198 mg (3 mmol) of potassium cyanide and heated to boiling under reflux for 22 hours. After evaporation in vacuo, the residue is treated with water and extracted three times with 30 ml of chloroform each time. The combined chloroform phases are washed three times with 20 ml of water each time, dried over magnesium sulphate and evaporated. After recrystallisation from ethyl acetate/n-hexane, there is obtained isopropyl (S)-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylate of melting point 207°-208° C.